Dopamine and G protein-coupled receptor kinase 4 in the kidney: Role in blood pressure regulation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 12, 2010, Pages 1259-1267

  Jose, Pedro A ^a   Soares da Silva, Patricio ^b   Eisner, Gilbert M ^c   Felder, Robin A ^d  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b University of Porto   (Portugal)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Dopamine; Dopamine receptors; Essential hypertension; G protein coupled receptor kinase 4; Sodium transport

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 4;

BLOOD PRESSURE REGULATION; ESSENTIAL HYPERTENSION; ETHNIC GROUP; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTENSION; INTERNALIZATION; KIDNEY FUNCTION; MORBIDITY; MORTALITY; NATRIURESIS; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; SECOND MESSENGER; SIGNAL TRANSDUCTION; SODIUM BALANCE; SODIUM EXCRETION;

ADULT; AMINO ACID SUBSTITUTION; ANIMALS; BLOOD PRESSURE; DOPAMINE; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 4; HUMANS; HYPERTENSION; KIDNEY; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUTATION, MISSENSE; PHOSPHORYLATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D3; RENIN-ANGIOTENSIN SYSTEM;

MUS MUSCULUS;

EID: 78049254400     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.02.004     Document Type: Review

References (196)

1. Zeng C., Armando I., Luo Y., Eisner G.M., Felder R.A., Jose P.A. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am. J. Physiol. Heart. Circ. Physiol. 2008, 294:H551-H569.
2. Hussain T., Lokhandwala M.F. Renal dopamine receptors and hypertension. Exp. Biol. Med. (Maywood). 2003, 228:134-142.
3. Alexander R.W., Gill J.R., Yamabe H., Lovenberg W., Keiser H.R. Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J. Clin. Invest. 1974, 54:194-200.
4. Carey R.M., VanLoon G.R., Baines A.D., Ortt E.M. Decreased plasma and urinary dopamine during dietary sodium depletion in man. J. Clin. Endocrinol. Metab. 1981, 52:903-909.
5. Maurel A., Spreux-Varoquaux O., Amenta F., Tayebati S.K., Tomassoni D., Seguelas M.H., Parini A., Pizzinat N. Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells. Am. J. Physiol. Renal Physiol. 2007, 292:F1592-F1598.
6. Pinho M.J., Serrão M.P., Soares-da-Silva P. High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 2007, 292:F1452-F1463.
7. Silva E., Gomes P., Soares-da-Silva P. Increases in transepithelial vectorial Na+transport facilitates Na+-dependent L-DOPA transport in renal OK cells. Life Sci. 2006, 79:723-729.
8. Choi M.R., Correa A.H., del Valle Turco V., Garcia F.A., Fernández B.E. Angiotensin II regulates extraneuronal dopamine uptake in the kidney. Nephron Physiol. 2006, 104:136-143.
9. Chen N., Reith M.E. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential. J. Neurochem. 2004, 89:750-765.
10. Damasceno A., Santos A., Serrão P., Caupers P., Soares-da-Silva P., Polónia J. Deficiency of renal dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive subjects in contrast to salt-resistant subjects. J. Hypertens. 1999, 17:1995-2001.
11. Sowers J.R., Zemel M.B., Zemel P., Beck F.W., Walsh M.F., Zawada E.T. Salt sensitivity in blacks. Salt intake and natriuretic substances. Hypertension 1988, 12:485-490.
12. Ferreira A., Bettencourt P., Pestana M., Correia F., Serrão P., Martins L., Cerqueira-Gomes M., Soares-Da-Silva P. Heart failure, aging, and renal synthesis of dopamine. Am. J. Kidney Dis. 2001, 38:502-509.
13. Wang Z.-Q., Siragy H.M., Felder R.A., Carey R.M. Intrarenal dopamine production and distribution in the rat: physiological control of sodium excretion. Hypertension 1997, 29:228-234.
14. Helms M.N., Self J., Bao H.F., Job L.C., Jain L., Eaton D.C. Dopamine activates amiloride-sensitive sodium channels in alveolar type I cells in lung slice preparations. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L610-L618.
15. Bertorello A.M., Komarova Y., Smith K., Leibiger I.B., Efendiev R., Pedemonte C.H., Borisy G., Sznajder J.I. Analysis of Na+, K+-ATPase motion and incorporation into the plasma membrane in response to G protein-coupled receptor signals in living cells. Mol. Biol. Cell 2003, 14:1149-1157.
16. Guerrero C., Lecuona E., Pesce L., Ridge K.M., Sznajder J.I. Dopamine regulates Na-K-ATPase in alveolar epithelial cells via MAPK-ERK-dependent mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:L79-L85.
17. Chen Z., Leibiger I., Katz A.I., Bertorello A.M. Pals-associated tight junction protein functionally links dopamine and angiotensin II to the regulation of sodium transport in renal epithelial cells. Br. J. Pharmacol. 2009, 158:486-489.
18. Cinelli A.R., Efendiev R., Pedemonte C.H. Trafficking of Na-K-ATPase and dopamine receptor molecules induced by changes in intracellular sodium concentration of renal epithelial cells. Am. J. Physiol. Renal Physiol. 2008, 295:F1117-F1125.
19. Gildea J.J., Israel J.A., Johnson A.K., Zhang J., Jose P.A., Felder R.A. Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension 2009, 54:1010-1016.
20. Kruse M.S., Adachi S., Scott L., Holtbäck U., Greengard P., Aperia A., Brismar H. Recruitment of renal dopamine 1 receptors requires an intact microtubulin network. Pflugers Arch. 2003, 445:534-539.
21. Bacic D., Capuano P., Baum M., Zhang J., Stange G., Biber J., Kaissling B., Moe O.W., Wagner C.A., Murer H. Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am. J. Physiol. Renal Physiol. 2005, 288:F740-F747.
22. Bacic D., Kaissling B., McLeroy P., Zou L., Baum M., Moe O.W. Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int. 2003, 64:2133-2141.
23. Khundmiri S.J., Lederer E. PTH and DA regulate Na-K ATPase through divergent pathways. Am. J. Physiol. Renal Physiol. 2002, 282:F512-F522..
24. Cunningham R., Biswas R., Brazie M., Steplock D., Shenolikar S., Weinman E.J. Signaling pathways utilized by PTH and dopamine to inhibit phosphate transport in mouse renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 2009, 296:F355-F361.
25. Amaral J.S., Pinho M.J., Soares-da-Silva P. Regulation of amino acid transporters in the rat remnant kidney. Nephrol. Dial. Transplant. 2009, 24:2058-2067.
26. Lanaspa M.A., Giral H., Breusegem S.Y., Halaihel N., Baile G., Catalán J., Carrodeguas J.A., Barry N.P., Levi M., Sorribas V. Interaction of MAP17 with NHERF3/4 induces translocation of the renal Na/Pi IIa transporter to the trans-Golgi. Am. J. Physiol. Renal Physiol. 2007, 292:F230-F242.
27. Efendiev R., Chen Z., Krmar R.T., Uhles S., Katz A.I., Pedemonte C.H., Bertorello A.M. The 14-3-3 protein translates the NA+, K+-ATPaseα1-subunit phosphorylation signal into binding and activation of phosphoinositide 3-kinase during endocytosis. J. Biol. Chem. 2005, 280:16272-16277.
28. Gomes P., Soares-da-Silva P. Dopamine-induced inhibition of Na+-K+-ATPase activity requires integrity of actin cytoskeleton in opossum kidney cells. Acta Physiol. Scand. 2002, 175:93-10.
29. Schafer J.A., Li L., Sun D. The collecting duct, dopamine and vasopressin-dependent hypertension. Acta Physiol. Scand. 2000, 168:239-244.
30. Kunimi M., Seki G., Hara C., Taniguchi S., Uwatoko S., Goto A., Kimura S., Fujita T. Dopamine inhibits renal Na+:HCO3- cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int. 2000, 57:534-543.
31. Baines A.D., Drangova R. Does dopamine use several signal pathways to inhibit Na-Pi transport in OK cells?. J. Am. Soc. Nephrol. 1998, 9:1604-1612.
32. Banday A.A., Lokhandwala M.F. Inhibition of natriuretic factors increases blood pressure in rats. Am. J. Physiol. Renal Physiol. 2009, 297:F397-F402.
33. Wang X., Armando I., Luo Y., Pascua A., Villar V.A., Asico L., Jones J.E., Escano C.S., Friedman P.A., Jose P.A. Dopamine D3 receptors directly regulate NHE3 in renal proximal tubules. J. Am. Soc. Nephrol. 2007, 18:597A.
34. Cocores J.A., Gold M.S. The Salted Food Addiction Hypothesis may explain overeating and the obesity epidemic. Med. Hypotheses 2009, 73:892-899.
35. Roitman M.F., Schafe G.E., Thiele T.E., Bernstein I.L. Dopamine and sodium appetite: antagonists suppress sham drinking of NaCl solutions in the rat. Behav. Neurosci. 1997, 111:606-611.
36. Fitzgerald P., Dinan T.G. Prolactin and dopamine: what is the connection? A review article. J. Psychopharmacol. 2008, 22(2 Suppl):12-19.
37. Lucas-Teixeira V.A., Hussain T., Serrão P., Soares-da-Silva P., Lokhandwala M.F. Intestinal dopaminergic activity in obese and lean Zucker rats: response to high salt intake. Clin. Exp. Hypertens 2002, 24:383-396.
38. Saveanu A., Jaquet P., Brue T., Barlier A. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas. Mol. Cell. Endocrinol. 2008, 286:206-213.
39. Cote T.E., Felder R., Kebabian J.W., Sekura R.D., Reisine T., Affolter H.U. D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase. J. Biol. Chem. 1986, 261:4555-4561.
40. Schteingart D.E. Drugs in the medical treatment of Cushing's syndrome. Expert Opin. Emerg. Drugs 2009, 14:661-671.
41. Kok P., Roelfsema F., Frölich M., van Pelt J., Meinders A.E., Pijl H. Bromocriptine reduces augmented thyrotropin secretion in obese premenopausal women. J. Clin. Endocrinol. Metab. 2009, 94:1176-1181.
42. van den Buuse M. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats. Clin. Exp. Pharmacol. Physiol. 1998, 25:661-668.
43. Sowers J.R., Viosca S.P., Windsor C., Korenman S.G. Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men. J. Endocrinol. Invest. 1983, 6:9-15.
44. Carey R.M., Sen S. Recent progress in the control of aldosterone secretion. Recent Prog. Horm. Res. 1986, 42:251-296.
45. Correa A.H., Choi M.R., Gironacci M., Aprile F., Fernández B.E. Atrial natriuretic factor decreases renal dopamine turnover and catabolism without modifying its release. Regul. Pept. 2008, 146:238-242.
46. Ibarra F., Crambert S., Eklöf A.C., Lundquist A., Hansell P., Holtbäck U. Prolactin, a natriuretic hormone, interacting with the renal dopamine system. Kidney Int. 2005, 68:1700-1707.
47. Zeng C., Luo Y., Asico L.D., Hopfer U., Eisner G.M., Felder R.A., Jose P.A. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension 2003, 42:787-792.
48. Zeng C., Asico L.D., Wang X., Hopfer U., Eisner G.M., Felder R.A., Jose P.A. Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR. Hypertension 2003, 41:724-729.
49. Li H., Armando I., Yu P., Escano C., Mueller S.C., Asico L., Pascua A., Lu Q., Wang X., Villar V.A., Jones J.E., Wang Z., Periasamy A., Lau Y.S., Soares-da-Silva P., Creswell K., Guillemette G., Sibley D.R., Eisner G., Gildea J.J., Felder R.A., Jose P.A. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J. Clin. Invest. 2008, 118:2180-2189.
50. Khan F., Spicarová Z., Zelenin S., Holtbäck U., Scott L., Aperia A. Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 2008, 295:F1110-F1116.
51. Yang J., Cui Z., He D., Ren H., Han Y., Yu C., Fu C., Wang Z., Yang C., Wang X., Zhou L., Asico L.D., Villar V.A., Hopfer U., Mi M., Zeng C., Jose P.A. Insulin increases D5 dopamine receptor expression and function in renal proximal tubule cells from Wistar-Kyoto rats. Am. J. Hypertens. 2009, 22:770-776.
52. Banday A.A., Fazili F.R., Lokhandwala M.F. Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C. Am. J. Physiol. Renal Physiol. 2007, 293:F877-F884.
53. Banday A.A. Lokhandwala MF Oxidative stress reduces renal dopamine D1 receptor-Gq/11alpha G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2. Am. J. Physiol. Renal Physiol. 2007, 293:F306-F315.
54. Han W., Li H., Villar V.A., Pascua A.M., Dajani M.I., Wang X., Natarajan A., Quinn M.T., Felder R.A., Jose P.A., Yu P. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 2008, 51:481-487.
55. Abílio V.C., Silva R.H., Carvalho R.C., Grassl C., Calzavara M.B., Registro S., D'Almeida V., Ribeiro Rde A., Frussa-Filho R. Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia. Neuropharmacology 2004, 47:263-272.
56. Armando I., Wang X., Villar V.A., Jones J.E., Asico L.D., Escano C., Jose P.A. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension 2007, 49:672-678.
57. Yang Z., Asico L.D., Yu P., Wang Z., Jones J.E., Escano C.S., Wang X., Quinn M.T., Sibley D.R., Romero G.G., Felder R.A., Jose P.A. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R96-R104.
58. Banday A.A., Marwaha A., Tallam L.S., Lokhandwala M.F. Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats. Diabetes 2005, 54:2219-2226.
59. Schiöth H.B., Fredriksson R. The GRAFS classification system of G-protein coupled receptors in comparative perspective. Gen. Comp. Endocrinol. 2005, 142:94-101.
60. Holmes A., Lachowicz J.E., Sibley D.R. Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology 2004, 47:1117-1134.
61. Kimura K., White B.H., Sidhu A. Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins: evidence that D-1 dopamine receptors can couple to both Gs and Go. J. Biol. Chem. 1995, 270:14672-14678.
62. Sidhu A., Kimura K., Uh M., White B.H., Patel S. Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins Gs and Gz. J. Neurochem. 1998, 70:2459-2467.
63. 5 dopamine receptors in the nephron. Hypertension 2003, 41:604-610.
64. Felder C.C., Jose P.A., Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J. Pharmacol. Exp. Ther. 1989, 248:171-175.
65. 1 dopamine receptors couple to multiple Galpha proteins in different brain regions. J. Neurochem. 2001, 78:981-990.
66. Vyas S.J., Eichberg J., Lokhandwala M.F. Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex. J. Pharmacol. Exp. Ther. 1992, 260:134-139.
67. Liu J., Wang F., Huang C., Long L.H., Wu W.N., Cai F., Wang J.H., Ma L.Q., Chen J.G. Activation of phosphatidylinositol-linked novel D1 dopamine receptor contributes to the calcium mobilization in cultured rat prefrontal cortical astrocytes. Cell. Mol. Neurobiol. 2009, 29:317-328.
68. Yu P.Y., Eisner G.M., Yamaguchi I., Mouradian M.M., Felder R.A., Jose P.A. Dopamine D1A receptor regulation of phospholipase C isoform. J. Biol. Chem. 1996, 271:19503-19508.
69. Sahu A., Tyeryar K.R., Vongtau H.O., Sibley D.R., Undieh A.S. D5 dopamine receptors are required for dopaminergic activation of phospholipase C. Mol. Pharmacol. 2009, 75:447-453.
70. So C.H., Verma V., Alijaniaram M., Cheng R., Rashid A.J., O'Dowd B.F., George S.R. Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol. Pharmacol. 2009, 75:843-854.
71. White B.H., Kimura K., Sidhu A. Inhibition of hormonally induced inositol trisphosphate production in transfected GH4C1 cells: a novel role for the D5 subtype of the dopamine receptor. Neuroendocrinology 1999, 69:209-216.
72. Richtand N.M. Behavioral sensitization, alternative splicing, and D3 dopamine receptor-mediated inhibitory function. Neuropsychopharmacology 2006, 31:2368-7.
73. Cho D.I., Beom S., Van Tol H.H., Caron M.G., Kim K.M. Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors. Biochem. Biophys. Res. Commun. 2006, 350:634-640.
74. Sen S., Nesse R., Sheng L., Stoltenberg S.F., Gleiberman L., Burmeister M., Weder A.B. Association between a dopamine-4 receptor polymorphism and blood pressure. Am. J. Hypertens. 2005, 18:1206-1210.
75. Pedrosa R., Gomes P., Hopfer U., Jose P.A., Soares-da-Silva P. Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am. J. Physiol. Renal Physiol. 2004, 287:F1059-F1066.
76. Senogles S.E. D2s dopamine receptor mediates phospholipase D and antiproliferation. Mol. Cell. Endocrinol. 2003, 209:61-69.
77. O'Sullivan G.J., Kinsella A., Grandy D.K., Tighe O., Croke D.T., Waddington J.L. Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor "knockouts": identification of D4:D1-like interactions. Synapse 2006, 59:107-118.
78. Felder R.A., Jose P.A. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat. Clin. Pract. Nephrol. 2006, 2:637-650.
79. Zeng C., Sanada H., Watanabe H., Eisner G.M., Felder R.A., Jose P.A. Functional genomics of the dopaminergic system in hypertension. Physiol. Genomics 2004, 19:233-246.
80. Lin C.Y., Varma M.G., Joubel A., Madabushi S., Lichtarge O., Barber D.L. Conserved motifs in somatostatin, D2-dopamine, and alpha 2B-adrenergic receptors for inhibiting the Na-H exchanger, NHE1. J. Biol. Chem. 2003, 278:15128-15135.
81. Kocinsky H.S., Girardi A.C., Biemesderfer D., Nguyen T., Mentone S., Orlowski J., Aronson P.S. Use of phospho-specific antibodies to determine the phosphorylation of endogenous Na+/H+exchanger NHE3 at PKA consensus sites. Am. J. Physiol. Renal Physiol. 2005, 289:F249-F258.
82. Albrecht F.E., Xu J., Moe O.W., Hopfer U., Simonds W.F., Orlowski J., Jose P.A. Regulation of NHE3 activity by G protein subunits in renal brush-border membranes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R1064-R1073.
83. +-phosphate cotransport by dopamine. Am. J. Physiol. 1993, 264:F618-F622.
84. Ba J., Brown D., Friedman P.A. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am. J. Physiol. Renal Physiol. 2003, 285:F1233-F1243.
85. Pedrosa R., Jose P.A., Soares-da-Silva P. Defective D1-like receptor-mediated inhibition of the Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells. Am. J. Physiol. Renal Physiol. 2004, 286:F1120-F1126.
86. Brismar H., Asghar M., Carey R.M., Greengard P., Aperia A. Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc. Natl Acad. Sci. USA 1998, 95:5573-5578.
87. Asghar M., Kansra V., Hussain T., Lokhandwala M.F. Hyperphosphorylation of Na-pump contributes to defective renal dopamine response in old rats. J. Am. Soc. Nephrol. 2001, 12:226-232.
88. Pedemonte C.H., Efendiev R., Bertorello A.M. Inhibition of Na, K-ATPase by dopamine in proximal tubule epithelial cells. Semin. Nephrol. 2005, 25:322-327.
89. Yao L.P., Li X.X., Yu P.Y., Xu J., Asico L.D., Jose P.A. Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 1998, 32:1049-1053.
90. Satoh T., Ominato M., Katz A.I. Different mechanisms of renal Na-K-ATPase regulation by dopamine in the proximal and distal nephron. Hypertens. Res. 1995 Jun, 18(Suppl 1):S137-S140.
91. Bertorello A.M., Sznajder J.I. The dopamine paradox in lung and kidney epithelia: sharing the same target but operating different signaling networks. Am. J. Respir. Cell Mol. Biol. 2005, 33:432-437.
92. Wang X., Escano C.S., Asico L., Li H., Jones J.E., Armando I., Jose P.A. Up-regulation of renal sodium transporters in distal tubules are preserved in D5 deficient mice treated with losartan. Hypertension 2008, 52:E36. Abstract.
93. Saito O., Ando Y., Kusano E., Asano Y. Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am. J. Physiol. Renal Physiol. 2001, 281:F114-F122.
94. Sun D., Schafer J.A. Dopamine inhibits AVP-dependent Na+transport and water permeability in rat CCD via a D4-like receptor. Am. J. Physiol. 1996, 271:F391-F400.
95. +-2Cl- cotransport in rat medullary thick ascending limb by dopamine. Am. J. Physiol. 1996, 271:R1561-R1567.
96. +-ATPase activity in murine LTK-cells. Mol. Pharmacol. 1996, 49:373-378.
97. Hazelwood L.A., Free R.B., Cabrera D.M., Skinbjerg M., Sibley D.R. Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+, K+-ATPase. J. Biol. Chem. 2008, 283:36441-36453.
98. Bagh M.B., Maiti A.K., Jana S., Banerjee K., Roy A., Chakrabarti S. Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's disease. Free Radic. Res. 2008, 42:574-581.
99. +-pump activity by dopamine in rat tail arteries. Eur. J. Pharmacol. 1995, 284:289-297.
100. Zeng C., Wang D., Yang Z., Wang Z., Asico L.D., Wilcox C.S., Eisner G.M., Welch W.J., Felder R.A., Jose P.A. Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 2004, 43:673-679.
101. Okamura T., Toda N. Comparison of the effect of dopamine in primate arteries and veins. Hypertens. Res. 1995, 18(Suppl 1):S35-S37.
102. Polakowski J.S., Segreti J.A., Cox B.F., Hsieh G.C., Kolasa T., Moreland R.B., Brioni J.D. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats. Clin. Exp. Pharmacol. Physiol. 2004, 31:837-841.
103. Han G., Kryman J.P., McMillin P.J., White R.E., Carrier G.O. A novel transduction mechanism mediating dopamine-induced vascular relaxation: opening of BKCa channels by cyclic AMP-induced stimulation of the cyclic GMP-dependent protein kinase. J. Cardiovasc. Pharmacol. 1999, 34:619-627.
104. Natarajan A., Han G., Chen S.Y., Yu P., White R., Jose P. The D5 dopamine receptor mediates large-conductance, calcium- and voltage-activated potassium channel activation in human coronary artery smooth muscle cells. J. Pharmacol. Exp. Ther. 2010, 332:640-649.
105. Siragy H.M., Felder R.A., Howell N.L., Chevalier R.L., Peach M.J., Carey R.M. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am. J. Physiol. 1989, 257:F469-F477.
106. Hegde S.S., Jadhav A.L., Lokhandwala M.F. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 1989, 13:828-834.
107. Felder R.A., Seikaly M.G., Cody P., Eisner G.M., Jose P.A. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 1990, 15:560-569.
108. 2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R1071-R1078.
109. 3 receptor activation in anesthetized rats. Am. J. Physiol. Renal Physiol. 2000, 278:F570-F575.
110. Sanada H., Xu J., Watanabe H., Jose P., Felder R. Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney. Am. J. Hypertens. 2000, 13:156A. Abstract.
111. Yao L.P., Huque E., Baraniuk J.N., Felder R.A., Carey R.M., Jose P.A. Dopamine-1 receptor subtype (D1A and D1B) expression in microdissected rat nephron segments. Pediatr Res. 1997, 41:286A. (Abstract).
112. Felder R.A., Sanada H., Xu J., Yu P.Y., Wang Z., Watanabe H., Asico L.D., Wang W., Zheng S., Yamaguchi I., Williams S.M., Gainer J., Brown N.J., Hazen-Martin D., Wong L.J., Robillard J.E., Carey R.M., Eisner G.M., Jose P.A. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc. Natl Acad. Sci. U. S. A. 2002, 99:3872-3877.
113. Rankin M.L., Marinec P.S., Cabrera D.M., Wang Z., Jose P.A., Sibley D.R. The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol. Pharmacol. 2006, 69:759-769.
114. Tiberi M., Nash S.R., Bertrand L., Lefkowitz R.J., Caron M.G. Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J. Biol. Chem. 1996, 271:3771-3778.
115. Gardner B., Liu Z.F., Jiang D., Sibley D.R. The role of phosphorylation/dephosphorylation in agonist-induced desensitization of D1 dopamine receptor function: evidence for a novel pathway for receptor dephosphorylation. Mol. Pharmacol. 2001, 59:310-321.
116. Gainetdinov R.R., Premont R.T., Bohn L.M., Lefkowitz R.J., Caron M.G. Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 2004, 27:107-144.
117. Zeng C., Villar V.A., Eisner G.M., Williams S.M., Felder R.A., Jose P.A. G protein-coupled receptor kinase 4: role in blood pressure regulation. Hypertension 2008, 51:1449-1455.
118. Pao C.S., Benovic J.L. Phosphorylation-independent desensitization of G protein-coupled receptors?. Sci. STKE 2002, 2002(153):PE42.
119. Premont R.T., Macrae A.D., Stoffel R.H., Chung N., Pitcher J.A., Ambrose C., Inglese J., MacDonald M.E., Lefkowitz R.J. Characterization of the G protein coupled receptor kinase GRK4. Identification of four splice variants. J. Biol. Chem. 1996, 271:6403-6410.
120. Fraga S., Jose P.A., Soares-da-Silva P. Involvement of G protein-coupled receptor kinase 4 and 6 in rapid desensitization of dopamine D1 receptor in rat IEC-6 intestinal epithelial cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R772-R779.
121. Watanabe H., Xu J., Bengra C., Jose P.A., Felder R.A. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int. 2002, 62:790-798.
122. Sanada H., Yatabe J., Midorikawa S., Katoh T., Hashimoto S., Watanabe T., Xu J., Luo Y., Wang X., Zeng C., Armando I., Felder R.A., Jose P.A. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 2006, 47:1131-1139.
123. Trivedi M., Lokhandwala M.F. Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats. Am. J. Physiol. Renal Physiol. 2005, 289:F298-F304.
124. Xu J., Watanabe H., Felder R.A., Jose P.A. GRK6 in the kidney in human and rat genetic hypertension. FASEB J. 2001, 15:A774.
125. Keever L.B., Jones J.E., Andresen B.T. G protein-coupled receptor kinase 4γ interacts with inactive Gαs and Gα13. Biochem. Biophys. Res. Commun. 2008, 367:649-655.
126. Premont R.T., Macrae A.D., Aparicio S.A.J.R., Kendall H.E., Welch J.E., Lefkowitz R.J. The GRK4 subfamily of G protein-coupled receptor kinases: alternative splicing, gene organization and sequence conservation. J. Biol. Chem. 1999, 274:29381-29389.
127. Virlon B., Firsov D., Cheval L., Reiter E., Troispoux C., Guillou F., Elalouf J.M. Rat G protein-coupled receptor kinase GRK4: identification, functional expression, and differential tissue distribution of two splice variants. Endocrinology 1998, 139:2784-2795.
128. Sallese M., Mariggiò S., Collodel G., Moretti E., Piomboni P., Baccetti B., De Blasi A. G protein-coupled receptor kinase GRK4. Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells. J. Biol. Chem. 1997, 272:10188-10189.
129. Villar V.A., Jones J.E., Armando I., Palmes-Saloma C., Yu P., Pascua A.M., Keever L., Arnaldo F.B., Wang Z., Luo Y., Felder R.A., Jose P.A. G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J. Biol. Chem. 2009, 284:21425-21434.
130. Iacovelli L., Salvatore L., Capobianco L., Picascia A., Barletta E., Storto M., Mariggio S., Sallese M., Porcellini A., Nicoletti F., De Blasi A. Role of G protein-coupled receptor kinase 4 andβ-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases. J. Biol. Chem. 2003, 278:12433-12442.
131. Pi M., Oakley R.H., Gesty-Palmer D., Cruickshank R.D., Spurney R.F., Luttrell L.M., Quarles L.D. Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization. Mol. Endocrinol. 2005, 19:1078-1087.
132. Perroy J., Adam L., Qanbar R., Chenier S., Bouvier M. Phosphorylation-independent desensitization of GABAB receptor by GRK4. EMBO J. 2003, 22:3816-3824.
133. B2 subunit with GRK4 or GRK5. J. Cell. Physiol. 2007, 210:237-245.
134. Munshi U.M., Peegel H., Menon K.M. Palmitoylation of the luteinizing hormone/human chorionic gonadotropin receptor regulates receptor interaction with the arrestin-mediated internalization pathway. Eur. J. Biochem. 2001, 268:1631-1639.
135. Lazari M.F., Liu X., Nakamura K., Benovic J.L., Ascoli M. Role of G protein-coupled receptor kinases on the agonist-induced phosphorylation and internalization of the follitropin receptor. Mol. Endocrinol. 1999, 13:866-878.
136. Menard L., Ferguson S.S., Barak L.S., Bertrand L., Premont R.T., Colapietro A.M., Lefkowitz R.J., Caron M.G. Members of the G protein-coupled receptor kinase family that phosphorylate the β2-adrenergic receptor facilitate sequestration. Biochemistry 1996, 35:4155-4160.
137. Oppermann M., Diverse-Pierluissi M., Drazner M.H., Dyer S.L., Freedman N.J., Peppel K.C., Lefkowitz R.J. Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. Proc. Natl Acad. Sci. USA 1996, 93:7649-7654.
138. Rane M.J., Prossnitz E.R., Arthur J.M., Ward R.A., McLeish K.R. Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated HL-60 cells. Biochem. Pharmacol. 2000, 60:179-187.
139. Iacovelli L., Capobianco L., Iula M., Di Giorgi Gerevini V., Picascia A., Blahos J., Melchiorri D., Nicoletti F., De Blasi A. Di Giorgi Gerevini V, Picascia A, Blahos J, Melchiorri D, Nicoletti F, De Blasi A. Regulation of mGlu4 metabotropic glutamate receptor signaling by type-2 G-protein coupled receptor kinase (GRK2). Mol. Pharmacol. 2004, 65:1103-1110.
140. Sorensen S.D., Conn P.J. G protein-coupled receptor kinases regulate metabotropic glutamate receptor 5 function and expression. Neuropharmacology 2003, 44:699-706.
141. Flannery P.J., Spurney R.F. Domains of the parathyroid hormone (PTH) receptor required for regulation by G protein-coupled receptor kinases (GRKs). Biochem. Pharmacol. 2001, 62:1047-1058.
142. Simon V., Robin M.T., Legrand C., Cohen-Tannoudji J. Endogenous G protein-coupled receptor kinase 6 triggers homologous β-adrenergic receptor desensitization in primary uterine smooth muscle cells. Endocrinology 2003, 144:3058-3066.
143. Tsuga H., Okuno E., Kameyama K., Haga T. Sequestration of human muscarinic acetylcholine receptor hm1-hm5 subtypes: effect of G protein-coupled receptor kinases GRK2, GRK4, GRK5 and GRK6. J. Pharmacol. Exp. Ther. 1998, 284:1218-1226.
144. Picascia A., Capobianco L., Iacovelli L., De Blasi A. Analysis of differential modulatory activities of GRK2 and GRK4 on Gαq-coupled receptor signaling. Methods Enzymol. 2004, 390:337-353.
145. van Balkom B.W., Hoffert J.D., Chou C.L., Knepper M.A. Proteomic analysis of long-term vasopressin action in the inner medullary collecting duct of the Brattleboro rat. Am. J. Physiol. 2004, 286:F216-F224.
146. Wang Z., Chen S., Asico L.D., Escano C., Villar V.M., Lu Q., Zeng C., Jones J.E., Armando I., Felder R.A., Jose P.A. AT1R dysregulation is crucial in the hypertension of human GRK4γ-142V transgenic mice. 2009 Experimental Biology meeting abstracts; D478 802. FASEB J. 2009, 23:802.7. Abstract.
147. Wang Z., Asico L., Wang X., Escano C., Jose P. Human G protein-coupled receptor kinase type 4γ (GRK4γ) 486V-promoted salt sensitivity in transgenic mice is related with increased AT1 receptor (AT1R). J. Am. Soc. Nephrol. 2007, 18:148A. Abstract.
148. Namkung Y., Dipace C., Javitch J.A., Sibley D.R. G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor. J. Biol. Chem. 2009, 284:15038-15051.
149. Ito K., Haga T., Lameh J., Sadée W. Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur. J. Biochem. 1999, 260:112-119.
150. So C.H., Verma V., O'Dowd B.F., George S.R. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor. Mol. Pharmacol. 2007, 72:450-462.
151. Kim K.M., Gainetdinov R.R., Laporte S.A., Caron M.G., Barak L.S. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation. J. Biol. Chem. 2005, 280:12774-12780.
152. Sanchez-Perez A., Kumar S., Cook D.I. GRK2 interacts with and phosphorylates Nedd4 and Nedd4-2. Biochem. Biophys. Res. Commun. 2007, 359:611-615.
153. Arthur J.W., Sanchez-Perez A., Cook D.I. Scoring of predicted GRK2 phosphorylation sites in Nedd4-2. Bioinformatics 2006, 22:2192-2195.
154. Kimura T., Allen P.B., Nairn A.C., Caplan M.J. Arrestins and spinophilin competitively regulate Na+, K+-ATPase trafficking through association with a large cytoplasmic loop of the Na+, K+-ATPase. Mol. Biol. Cell 2007, 18:4508-4518.
155. Menco B.P. The fine-structural distribution of G-protein receptor kinase 3, beta-arrestin-2, Ca2+/calmodulin-dependent protein kinase II and phosphodiesterase PDE1C2, and a Cl- cotransporter in rodent olfactory epithelia. J. Neurocytol. 2005, 34:11-36.
156. Stason W.B. Hypertension: a policy perspective, 1976-2008. J. Am. Soc. Hypertens. 2009, 3:113-118.
157. Sander G.E. High blood pressure in the geriatric population: treatment considerations. Am. J. Geriatr. Cardiol. 2002, 11:223-232.
158. Harrison M., Maresso K., Broeckel U. Genetic determinants of hypertension: an update. Curr. Hypertens. Rep. 2008, 10:488-495.
159. Harrap S.B. Blood pressure genetics: time to focus. J. Am. Soc. Hypertens. 2009, 3:231-237.
160. Newton-Cheh C., et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 2009, 41:666-676.
161. Levy D., et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 2009, 41:667-687.
162. Adeyemo A., Gerry N., Chen G., Herbert A., Doumatey A., Huang H., Zhou J., Lashley K., Chen Y., Christman M., Rotimi C. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 2009, 5:e1000564.
163. Wang Y., O'Connell J.R., McArdle P.F., Wade J.B., Dorff S.E., Shah S.J., Shi X., Pan L., Rampersaud E., Shen H., Kim J.D., Subramanya A.R., Steinle N.I., Parsa A., Ober C.C., Welling P.A., Chakravarti A., Weder A.B., Cooper R.S., Mitchell B.D., Shuldiner A.R., Chang Y.P. From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc. Natl Acad. Sci. U. S. A. 2009, 106:226-231.
164. Cho Y.S., Go M.J., Kim Y.J., Heo J.Y., Oh J.H., Ban H.J., Yoon D., Lee M.H., Kim D.J., Park M., Cha S.H., Kim J.W., Han B.G., Min H., Ahn Y., Park M.S., Han H.R., Jang H.Y., Cho E.Y., Lee J.E., Cho N.H., Shin C., Park T., Park J.W., Lee J.K., Cardon L., Clarke G., McCarthy M.I., Lee J.Y., Lee J.K., Oh B., Kim H.L. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat. Genet. 2009, 41:527-534.
165. Moore J.H., Williams S.M. New strategies for identifying gene-gene interactions in hypertension. Ann. Med. 2002, 34:88-95.
166. Glazier A.M., Nadeau J.H., Aitman T.J. Finding genes that underlie complex traits. Science 2002, 298:2345-2349.
167. Escano C.S., Armando I., Wang X., Asico L., Pascua A., Yang Y., Wang Z., Lau Y.S., Jose P.A. Renal dopaminergic defect in C57BL/6J mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297. R1660-R1669.
168. Armando I., Jones J.E., Escano C., Asico L., Premont R.T., Jose P.A. [P-194] Deletion of the GRK4 gene decreases blood pressure and reverses salt sensitivity in mice. 2008 Meeting 2008, American Society of Hypertension, New Orleans, LA.
169. Chen W., Li S., Srinivasan S.R., Boerwinkle E., Berenson G.S. Autosomal genome scan for loci linked to blood pressure levels and trends since childhood: the Bogalusa Heart Study. Hypertension 2005, 45:954-959.
170. Allayee H., Dominguez K.M., Aouizerat B.E., Krauss R.M., Rotter J.I., Lu J., Cantor R.M., de Bruin T.W., Lusis A.J. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 2001, 38:773-778.
171. Zhu H., Lu Y., Wang X., Treiber F.A., Harshfield G.A., Snieder H., Dong Y. The G protein-coupled receptor kinase gene affects blood pressure in young normotensive twins. Am. J. Hypertens. 2006, 19:61-66.
172. Bengra C., Mifflin T.E., Khripin Y., Manunta P., Williams S.M., Jose P.A., Felder R.A. Genotyping essential hypertension SNPs using a homogenous PCR method with universal energy transfer primers. Clin. Chem. 2002, 48:2131-2140.
173. Williams S.M., Ritchie M.D., Phillips J.A., Addy J.H., Kpodonu J., Wong L.-J., Felder R.A., Jose P.A., Moore J.H. Identification of multilocus genotypes that associate with high-risk and low-risk for hypertension. Hum. Hered. 2004, 57:28-38.
174. Sanada H., Yatabe J., Midorikawa S., Hashimoto S., Watanabe T., Moore J.H., Ritchie M.D., Williams S.M., Pezzullo J.C., Sasaki M., Eisner G.M., Jose P.A., Felder R.A. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin. Chem. 2006, 52:352-360.
175. Speirs H.J., Katyk K., Kumar N.N., Benjafield A.V., Wang W.Y., Morris B.J. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J. Hypertens. 2004, 22:931-936.
176. Gu D., Su S., Ge D., Chen S., Huang J., Li B., Chen R., Qiang B. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 2006, 47:1147-1154.
177. Williams S.M., Addy J.A., Phillips J.A.I.I.I., Dai M., Kpodonu J., Afful J., Jackson H., Joseph K., Eason F., Murray M.M., Epperson P., Aduonum A., Wong L.-J., Jose P.A., Felder R.A. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000, 36:2-6.
178. Rana B.K., Insel P.A., Payne S.H., Abel K., Beutler E., Ziegler M.G., Schork N.J., O'Connor D.T. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 2007, 49:96-106.
179. Staessen J.A., Kuznetsova T., Zhang H., Maillard M., Bochud M., Hasenkamp S., Westerkamp J., Richart T., Thijs L., Li X., Brand-Herrmann S.M., Burnier M., Brand E. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 2008, 51:1643-1650.
180. Grant F.D., Romero J.R., Jeunemaitre X., Hunt S.C., Hopkins P.N., Hollenberg N.H., Williams G.H. Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension 2002, 39:191-196.
181. Sugimoto K., Hozawa A., Katsuya T., Matsubara M., Ohkubo T., Tsuji I., Motone M., Higaki J., Hisamachi S., Imai Y., Ogihara T. αl-Adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study. J. Hypertens. 2002, 20:1779-1784.
182. Lohmueller K.E., Wong L.J., Mauney M.M., Jiang L., Felder R.A., Jose P.A., Williams S.M. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann. Hum. Genet. 2006, 70:27-24.
183. Yu P., Asico L.D., Luo Y., Andrews P., Eisner G.M., Hopfer U., Felder R.A., Jose P.A. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int. 2006, 70:1072-1079.
184. Gildea J.J., Yatabe J., Sasaki M., Jose P.A., Felder R.A. G-protein coupled receptor kinase 4 (GRK4) polymorphisms block receptor recruitment to cell membranes. Hypertension 2006, 48:e85. Abstract.
185. Wang Z., Armando I., Asico L.D., Escano C., Wang X., Lu Q., Felder R.A., Schnackenberg C.G., Sibley D.R., Eisner G.M., Jose P.A. The elevated blood pressure of human GRK4γA142V transgenic mice is not associated with increased ROS production. Am. J. Physiol. Heart. Circ. Physiol. 2007, 292:H2083-H2092.
186. Wang Z., Asico L.D., Escano C.S., Felder R.A., Jose P.A. Human G protein-coupled receptor kinase type 4γ (hGRK4γ) wild-type prevents salt sensitivity while its variant, hGRK4γ486V, promotes salt sensitivity in transgenic mice: role of genetic background. Hypertension 2006, 48:e27.
187. Zhu H., Lu Y., Wang X., Snieder H., Treiber F.A., Harshfield G.A., Dong Y. The G protein-coupled receptor kinase 4 gene modulates stress-induced sodium excretion in black normotensive adolescents. Pediatr. Res. 2006, 60:440-442.
188. Gros R., Chorazyczewski J., Meek M.D, Benovic J.L., Ferguson S.S., Feldman R.D. G-Protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension 2000, 35:38-42.
189. Eckhart A.D., Ozaki T., Tevaearai H., Rockman H.A., Koch W.J. Vascular targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol. Pharmacol. 2002, 61:749-758.
190. Touyz R.M., Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 2000, 52:639-672.
191. Dinudom A., Fotia A.B., Lefkowitz R.J., Young J.A., Kumar S., Cook D.I. The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na channels. Proc. Natl Acad. Sci. USA 2004, 101:11886-11889.
192. Cohn H.I., Xi Y., Pesant S., Harris D.M., Hyslop T., Falkner B., Eckhart A.D. G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans. Hypertension 2009, 54:71-76.
193. Keys J.R., Zhou R.H., Harris D.M., Druckman C.A., Eckhart A.D. Vascular smooth muscle overexpression of G protein-coupled receptor kinase 5 elevates blood pressure, which segregates with sex and is dependent on Gi-mediated signaling. Circulation 2005, 112:1145-1153.
194. Ishizaka N., Alexander R.W., Laursen J.B., Kai H., Fukui T., Oppermann M., Lefkowitz R.J., Lyons P.R., Griendling K.K. G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta. Regulation by angiotensin II and hypertension. J. Biol. Chem. 1997, 272:32482-32488.
195. Bhatnagar V., O'Connor D.T., Brophy V.H., Schork N.J., Richard E., Salem R.M., Nievergelt C.M., Bakris G.L., Middleton J.P., Norris K.C., Wright J., Hiremath L., Contreras G., Appel L.J., Lipkowitz M.S. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am. J. Hypertens. 2009, 22:332-338. AASK Study Investigators.
196. Sanada H., Yatabe J., Yatabe M.S., Yokokawa H., Williams S., Bartlett J., Wang Z., Felder R., Jose P.A. G Protein-coupled receptor type 4 gene variants and response to antihypertensive medication. Circulation 2009, 120:S1087. Abstract 5413.